Chapter 1 Transcription factor genes in type 2 diabetes

Advances in Molecular and Cellular Endocrinology

Volumn 5, Issue C, 2006, Pages 1-14

  Weedon, Michael N ^a   Hattersley, Andrew T ^a   Frayling, Timothy M ^a  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957060634     PISSN: 15692566     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-2566(06)05001-0     Document Type: Review

References (74)

1. Stumvoll M., and Haring H. The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism. Diabetes 51 8 (2002) 2341-2347
2. Florez J.C., Hirschhorn J.N., and Altshuler D. The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits. Annu. Rev. Genomics. Hum. Genet. 4 (2003) 257-291
3. Florez J.C. Phenotypic consequences of the peroxisome proliferator-activated receptor-gamma pro12ala polymorphism: the weight of the evidence in genetic association studies. J. Clin. Endocrinol. Metab. 89 9 (2004) 4234-4237
4. Fajans S.S., Bell G.I., and Polonsky K.S. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N. Engl. J. Med. 345 13 (2001) 971-980
5. Owen K., and Hattersley A.T. Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization. Best Pract. Res. Clin. Endocrinol. Metab. 15 3 (2001) 309-323
6. Stride A., and Hattersley A.T. Different genes. different diabetes: lessons from maturity-onset diabetes of the young, Ann. Med. 34 3 (2002) 207-216
7. Barroso I., Gurnell M., Crowley V.E., Agostini M., Schwabe J.W., Soos M.A., et al. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402 6764 (1999) 880-883
8. Savage D.B., Tan G.D., Acerini C.L., Jebb S.A., Agostini M., Gurnell M., et al. Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma. Diabetes 52 4 (2003) 910-917
9. Altshuler D., Hirschhorn J.N., Klannemark M., Lindgren C.M., Vohl M.-C., Nemesh J., et al. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat. Genet. 26 (2000) 76-80
10. Risch N., and Merikangas K. The future of genetic studies of complex human diseases. Science 273 (1996) 1516-1517
11. Masud S., and Ye S. group S. Effect of the peroxisome proliferator activated receptor-gamma gene Pro12Ala variant on body mass index: a meta-analysis. J. Med. Genet. 40 10 (2003) 773-780
12. Hattersley A.T., Turner R.C., Permutt M.A., Patel P., Tanizawa Y., Chiu K.C., et al. Linkage of type 2 diabetes to the glucokinase gene. Lancet 339 (1992) 1307-1310
13. Vionnet N., Stoffel M., Takeda J., Yasuda K., Bell G.I., Zouali H., et al. Nonsense mutation in the glucokinase gene causes early onset non-insulin-dependent diabetes mellitus. Nature 356 6371 (1992) 721-722
14. Froguel P., Vaxillaire M., Sun F., Velho G., Zouali H., Butel M.O., et al. Close linkage of glucokinase locus on chromosome 7p to early onset non-insulin-dependent diabetes mellitus. Nature 356 (1992) 162-164
15. Yamagata K., Oda N., Kaisaki P.J., Menzel S., Furuta H., Vaxillaire M., et al. Mutations in the hepatic nuclear factor 1 alpha gene in maturity-onset diabetes of the young (MODY3). Nature 384 (1996) 455-458
16. Yamagata K., Furuta H., Oda N., Kaisaki P.J., Menzel S., Cox N.J., et al. Mutations in the hepatocyte nuclear factor 4 alpha gene in maturity-onset diabetes of the young (MODY1). Nature 384 (1996) 458-460
17. Horikawa Y., Iwasaki N., Hara M., Furuta H., Hinokio Y., Cockburn B., et al. Mutation in hepatocyte nuclear factor-1b gene (TCF2) associated with MODY. Nat. Genet. 17 (1997) 384-385
18. Stoffers D.A., Ferrer J., Clarke W.L., and Habener J.F. Early onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat. Genet. 17 (1997) 138-139
19. Malecki M.T., Jhala U.S., Antonellis A., Fields L., Doria A., Orban T., et al. Mutations in NEUROD1 are associated with the development of Type 2 diabetes mellitus. Nat. Genet. 23 3 (1999) 323-328
20. Pearson E.R., Starkey B.J., Powell R.J., Gribble F.M., Clark P.M., and Hattersley A.T. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 362 9392 (2003) 1275-1281
21. Gloyn A., and McCarthy M. The genetics of type 2 diabetes. Best practice and research clinical endocrinology and metabolism 15 9 (2001) 293-308
22. Online Mendelian Inheritance in Man, OMIM (TM), in: McKusick-Nathans Institute for Genetic Medicine, John Hopkins University, Baltimore, MD and National Center for Biotechnology Information, National Library of Medicine, Bethesda, MD. 2000.
23. Pociot F., and McDermott M.F. Genetics of type 1 diabetes mellitus. Genes Immun 3 5 (2002) 235-249
24. Horikawa Y., Oda N., Cox N.J., Li X., Orho-Melander M., Hara M., et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet. 26 2 (2000) 163-175
25. Weedon M.N., Schwarz P.E., Horikawa Y., Iwasaki N., Illig T., Holle R., et al. Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility. Am. J. Hum. Genet. 73 6 (2003) 1208-1212
26. McCarthy M.I. Growing evidence for diabetes susceptibility genes from genome scan data. Curr. Diab. Rep. 3 2 (2003) 159-167
27. Ferrer J. A genetic switch in pancreatic beta-cells: implications for differentiation and haploinsufficiency. Diabetes 51 8 (2002) 2355-2362
28. Frayling T.M., Evans J.C., Bulman M.P., Pearson E., Allen L., Owen K., et al. Beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes 50 Suppl 1 (2001) S94-S100
29. Mahtani M.M., Widen E., Lehto M., Thomas J., McCarthy M., Brayer J., et al. Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat. Genet. 14 1 (1996) 90-94
30. Reynisdottir I., Thorleifsson G., Benediktsson R., Sigurdsson G., Emilsson V., Einarsdottir A.S., et al. Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2. Am. J. Hum. Genet. 73 2 (2003) 323-335
31. Hegele R.A., Zinman B., Hanley A.J., Harris S.B., Barrett P.H., and Cao H. Genes environment and Oji-Cree type 2 diabetes. Clin. Biochem. 36 3 (2003) 163-170
32. Hegele R.A., Cao H., Harris S.B., Hanley A.J., and Zinman B. The hepatic nuclear factor-1alpha G319S variant is associated with early onset type 2 diabetes in Canadian Oji-Cree. J. Clin. Endocrinol. Metab. 84 3 (1999) 1077-1082
33. Abderrahim E., Ben Moussa F., Ben Abdallah T., Hedri H., Goucha R., Ben Hamida F., et al. Glomerulocystic kidney disease in an adult presenting as end-stage renal failure. Nephrol. Dial. Transplant. 14 (1999) 1276-1278
34. Harries L.W., Hattersley A.T., and Ellard S. Messenger RNA transcripts of the hepatocyte nuclear factor-1alpha gene containing premature termination codons are subject to nonsense-mediated decay. Diabetes 53 2 (2004) 500-504
35. Triggs-Raine B.L., Kirkpatrick R.D., Kelly S.L., Norquay L.D., Cattini P.A., Yamagata K., et al. HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community. Proc,. Natl. Acad. Sci. USA. 99 7 (2002) 4614-4619
36. Urhammer S.A., Rasmussen S.K., Kaisaki P.J., Oda N., Yamagata K., Moller A.M., et al. Genetic variation in the hepatocyte nuclear factor-1α gene in Danish Caucasians with late onset NIDDM. Daibetologia 40 (1997) 473-475
37. Urhammer S.A., Fridberg M., Hansen T., Rasmussen S.K., Moller A.M., Clausen J.O., et al. A prevalent amino acid polymorphism at codon 98 in the hepatocyte nuclear factor-1alpha gene is associated with reduced serum C-peptide and insulin responses to an oral glucose challenge. Diabetes 46 5 (1997) 912-916
38. Urhammer S.A., Hansen T., Ekstrom C.T., Eiberg H., and Pedersen O. The Ala/Val98 polymorphism of the hepatocyte nuclear factor-1alpha gene contributes to the interindividual variation in serum C-peptide response during an oral glucose tolerance test: evidence from studies of 231 glucose-tolerant first degree relatives of type 2 diabetic probands. J. Clin. Endocrinol. Metab. 83 12 (1998) 4506-4509
39. Rissanen J., Wang H., Miettinen R., Karkkainen P., Kekalainen P., Mykkanen L., et al. Variants in the hepatocyte nuclear factor-1alpha and -4alpha genes in Finnish and Chinese subjects with late-onset type 2 diabetes. Diabetes Care 23 10 (2000) 1533-1538
40. Deng H., Tang W.L., and Liu Z. Relationship between Ala98Val variant of hepatocyte nuclear factor-1 alpha gene and late-onset type 2 diabetes in Han nationality. Hunan Yi Ke Da Xue Xue Bao 28 2 (2003) 93-94
41. Behn P.S., Wasson J., Chayen S., Smolovitch I., Thomas J., Glaser B., et al. Hepatocyte nuclear factor 1alpha coding mutations are an uncommon contributor to early onset type 2 diabetes in Ashkenazi Jews. Diabetes 47 6 (1998) 967-969
42. Baier L.J., Permana P.A., Traurig M., Dobberfuhl A., Wiedrich C., Sutherland J., et al. Mutations in the genes for hepatocyte nuclear factor (HNF)-1alpha, -4alpha, -1beta, and -3beta; the dimerization cofactor of HNF-1; and insulin promoter factor 1 are not common causes of early onset type 2 diabetes in Pima Indians. Diabetes Care 23 3 (2000) 302-304
43. Urhammer S.A., Moller A.M., Nyholm B., Ekstrom C.T., Eiberg H., Clausen J.O., et al. The effect of two frequent amino acid variants of the hepatocyte nuclear factor-1alpha gene on estimates of the pancreatic beta-cell function in Caucasian glucose-tolerant first-degree relatives of type 2 diabetic patients. J Clin. Endocrinol. Metab. 83 11 (1998) 3992-3995
44. Chiu K.C., Chuang L.M., Chu A., and Wang M. Transcription factor 1 and beta-cell function in glucose-tolerant subjects. Diabet. Med. 20 3 (2003) 225-230
45. Chiu K.C., Chuang L.M., Chu A., Yoon C., and Wang M. Comparison of the impact of the I27L polymorphism of the hepatocyte nuclear factor-1alpha on estimated and measured beta cell indices. Eur. J. Endocrinol. 148 6 (2003) 641-647
46. Gloyn A.L., Weedon M.N., Owen K.R., Turner M.J., Knight B.A., Hitman G., et al. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23 K variant is associated with type 2 diabetes,. Diabetes 52 2 (2003) 568-572
47. Hirschhorn J.N., Lohmueller K., Byrne E., and Hirschhorn K. A comprehensive review of genetic association studies. Genet. Med. 4 2 (2002) 45-61
48. Ghosh S., Watanabe R.M., Hauser E.R., Valle T., Magnuson V.L., Erdos M.R., et al. Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc. Natl. Acad. Sci. USA. 96 5 (1999) 2198-2203
49. Permutt M.A., Wasson J., Love-Gregory L., Ma J., Skolnick G., Suarez B., et al. Searching for type 2 diabetes genes on chromosome 20. Diabetes 51 Suppl 3 (2002) S308-S315
50. Thomas H., Jaschkowitz K., Bulman M., Frayling T.M., Mitchell S.M.S., Roosen S., et al. A distant upstream promoter of the HNF-4alpha gene connects the transcription factors involved in maturity-onset diabetes of the young. Hum. Mol. Genet. 10 19 (2001) 2089-2097
51. Hansen S.K., Parrizas M., Jensen M.L., Pruhova S., Ek J., Boj S.F., et al. Genetic evidence that HNF-1alpha-dependent transcriptional control of HNF-4alpha is essential for human pancreatic beta cell function. J. Clin. Invest. 110 6 (2002) 827-833
52. Mitchell S.M.S., Vaxillaire M., Thomas H., Parrizas M., Benmezroua Y., Costa A., et al. Rare variants identified in the HNF-4α b-cell specific promoter and alternative exon 1 lack biological significance in maturity onset diabetes of the young and type 2 diabetes. Diabetelogia 45 9 (2002) 1344-1348
53. Silander K., Mohlke K.L., Scott L.J., Peck E.C., Hollstein P., Skol A.D., et al. Genetic variation near the hepatocyte nuclear factor-4alpha gene predicts susceptibility to type 2 diabetes. Diabetes 53 (2004) 1141-1149
54. Love-Gregory L.D., Wasson J., Ma J., Jin C.H., Glaser B., Suarez B.K., et al. A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4alpha gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an Ashkenazi Jewish population. Diabetes 53 (2004) 1134-1140
55. Weedon M.N., Owen K.R., Shields B., Hitman G., Walker M., McCarthy M.I., et al. Common variants of the hepatocyte nuclear factor-4alpha P2 promoter are associated with type 2 diabetes in the UK population. Diabetes 53 11 (2004) 3002-3006
56. Macfarlane W.M., Smith S.B., James R.F.L., Clifton A.D., Doza Y.N., Cohen P., et al. The p38/reactiviating kinase mitogen activated protein kinase cascade mediates the activation of the transcription factor IUF1 and insulin gene transcription by high glucose in pancreatic beta-cells. J. Biol.Chem. 272 (1997) 20936-20944
57. Macfarlane W.M., McKinnon C.M., Felton-Edkins Z.A., Cragg H., James R.F.L., and Docherty K. Glucose stimulates translocation of the homeodomain transcription factor PDX1 from the cytoplasm to the nucleus in pancreatic β-cells. J. Biol. Chem. 274 (1999) 1011-1016
58. Stoffers D.A., Zinkin N.T., Stanojevic V., Clarke W.L., and Habener J.F. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat. Genet. 15 (1997) 106-110
59. Macfarlane W., Frayling T., Ellard S., Evans J., Allen L., Bulman M., et al. Missense mutations in the insulin promoter factor 1 (IPF-1) gene predispose to type 2 diabetes. J. Clin. Invest. 104 (1999) R33-R39
60. Hani E.H., Stoffers D.A., Chevre J.C., Durand E., Stanojevic V., Dina C., et al. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus. J. Clin. Invest. 104 9 (1999) R41-R48
61. Weng J., Macfarlane W.M., Lehto M., Gu H.F., Shepherd L.M., Ivarsson S.A., et al. Functional consequences of mutations in the MODY4 gene (IPF1) and coexistence with MODY3 mutations. Diabetologia 44 2 (2001) 249-258
62. Silver K., and Shetty A. IPF-1 gene variation and the development of type 2 diabetes. Mol. Genet. Metab. 75 3 (2002) 287-289
63. Reis A.F., Ye W.Z., Dubois-Laforgue D., Bellanne-Chantelot C., Timsit J., and Velho G. Mutations in the insulin promoter factor-1 gene in late-onset type 2 diabetes mellitus. Eur. J. Endocrinol. 143 4 (2000) 511-513
64. Hansen L., Urioste S., Petersen H.V., Jensen J.N., Eiberg H., Barbetti F., et al. Missense mutations in the human insulin promoter factor-1 gene and their relation to maturity-onset diabetes of the young and late-onset type 2 diabetes mellitus in Caucasians. J. Clin. Endocrinol. Metab. 85 3 (2000) 1323-1326
65. Iwata I., Nagafuchi S., Nakashima H., Kondo S., Koga T., Yokogawa Y., et al. Association of polymorphism in the NeuroD/BETA2 gene with type 1 diabetes in the Japanese. Diabetes 48 2 (1999) 416-419
66. Malecki M.T., Klupa T., Moczulski D.K., and Rogus J.J. The Ala45Thr polymorphism of BETA2/NeuroD1 gene and susceptibility to type 1 diabetes mellitus in Caucasians. Exp. Clin. Endocrinol. Diabetes 111 5 (2003) 251-254
67. Yamada S., Motohashi Y., Yanagawa T., Maruyama T., Kasuga A., Hirose H., et al. NeuroD/beta2 gene G ->A polymorphism may affect onset pattern of type 1 diabetes in Japanese. Diabetes Care 24 8 (2001) 1438-1441
68. Hansen L., Jensen J.N., Urioste S., Petersen H.V., Pociot F., Eiberg H., et al. NeuroD/BETA2 gene variability and diabetes: no associations to late-onset type 2 diabetes but an A45 allele may represent a susceptibility marker for type 1 diabetes among Danes. Danish Study Group of Diabetes in Childhood, and the Danish IDDM Epidemiology and Genetics Group. Diabetes 49 5 (2000) 876-878
69. Dupont S., Dina C., Hani E.H., and Froguel P. Absence of replication in the French population of the association between beta 2/NEUROD-A45T polymorphism and type 1 diabetes. Diabetes Metab 25 6 (1999) 516-517
70. Awata T., Inoue K., Inoue I., Abe T., Takino H., Kanazawa Y., et al. Lack of association of the Ala45Thr variant in the BETA2/NEUROD1 with type 1 diabetes in Japanese. Diabetes Res. Clin. Pract. 49 1 (2000) 61-63
71. Vella A., Howson J.M., Barratt B.J., Twells R.C., Rance H.E., Nutland S., et al. Lack of association of the Ala(45)Thr polymorphism and other common variants ot the NeuroD gene with type 2 diabetes. Diabetes 53 4 (2004) 1158-1161
72. Malecki M.T., Cyganek K., Klupa T., and Sieradzki J. The Ala45Thr polymorphism of BETA2/NeuroD1 gene and susceptibility to type 2 diabetes mellitus in a Polish population. Acta Diabetol 40 2 (2003) 109-111
73. Ek J., Grarup N., Urhammer S.A., Gaede P.H., Drivsholm T., Borch-Johnsen K., et al. Studies of the variability of the hepatocyte nuclear factor-1beta (HNF-1beta/TCF2) and the dimerization cofactor of HNF-1 (DcoH/PCBD) genes in relation to type 2 diabetes mellitus and beta-cell function. Hum,. Mutat 18 4 (2001) 356-357
74. Babaya N., Ikegami H., Kawaguchi Y., Fujisawa T., Nakagawa Y., Hamada Y., et al. Hepatocyte nuclear factor-1alpha gene and non-insulin-dependent diabetes mellitus in the Japanese population. Acta Diabetol 35 3 (1998) 150-153